Details of the Drug Reposition

General Information of This Drug (ID: DM32148)

Drug Name
CD19 CAR T cells   DM32148
Drug Type
CAR T Cell Therapy

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
2 Phase 2/3 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Acute lymphoblastic leukaemia DIS87TGM 2A85 Phase 2/3 [1]
B-cell lymphoma DISIH1YQ 2A86 Phase 2/3 [2]
------------------------------------------------------------------------------------

References

1 ClinicalTrials.gov (NCT03391739) CART-19 Cells For R/R B-ALL
2 ClinicalTrials.gov (NCT03391726) CART-19 Cells for R/R B-cell Lymphoma